Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

U.S. President Donald Trump listens as Moncef Slaoui, the former head of GlaxoSmithKlines vaccines division, speaks about coronavirus vaccine development in the Rose Garden of the White House on May 15, 2020 in Washington, DC. Dubbed "Operation Warp Speed," the Trump administration is announcing plans for an all-out effort to produce and distribute a coronavirus vaccine by the end of 2020. (Photo: Drew Angerer/Getty Images)

U.S. President Donald Trump listens as Moncef Slaoui, the former head of GlaxoSmithKlines vaccines division, speaks about coronavirus vaccine development in the Rose Garden of the White House on May 15, 2020 in Washington, DC. Dubbed "Operation Warp Speed," the Trump administration is announcing plans for an all-out effort to produce and distribute a coronavirus vaccine by the end of 2020. (Photo: Drew Angerer/Getty Images)

Ethics Complaint Filed to Force Trump's Covid-19 Vaccine Czar—a Former Pharma Exec—to Submit to Ethics Rules

"Trump has put a pharmaceutical executive in charge of handing out the government contracts for coronavirus vaccine development. How could this possibly go wrong?"

Jon Queally

A pair of consumer watchdog groups on Thursday filed a formal federal ethics complaint stating that President Donald Trump's so-called "Vaccine Czar"—a former pharmaceutical executive with deep personal investments in the industry—should be forced to submit to the same conflict of interest and financial disclosure rules as other government officials charged with overseeing large sums of taxpayer money, especially as he stands to personally profit from his duties.

"Slaoui's blatant ties to Big Pharma, including the very drug corporations he's funneling money to, should make even the Trump administration blush."
—Margarida Jorge, Lower Drug Prices Now

The complaint—filed by Public Citizen and Lower Drug Prices Now filed with the inspector general of the U.S. Department of Health and Human Services (HHS) and the Office of Government Ethics (OGE)—targets Moncef Slaoui, selected by Trump earlier this month to help lead what the White House dubbed "Operation Warp Speed," a task force charged with leading the government's effort to find treatments and a possible vaccine to the Covid-19 virus.

A former executive at pharma giant GlaxoSmithKline, Slaoui has refused to divest his stock holdings in the company—"This is my retirement," he said earlier this month—and Trump has labeled him as a private contractor instead of a government employee. The complaint, however, says Slaoui—given that he will be in charge of awarding contracts and directing large sums of public resources—should be labeled as a special government employee (SGE) which would then require stricter ethical standards and disclosure requirements.

According to the complaint:

The contractual arrangement that regards Slaoui as merely a private contractor appears unwarranted and designed primarily to allow Slaoui to maintain an extensive web of conflicting financial interests without the need to divest of, recuse from or disclose those conflicting interests. This would otherwise constitute a violation of federal ethics laws. The arrangement provides Slaoui with the opportunity to enrich himself, his colleagues and his employers, and calls into question the integrity of critically-important official actions that will be taken under the Warp Speed program.

"Slaoui is a venture capitalist in the pharmaceutical industry who personally stands to make a fortune from determining winners and losers in the race to develop a vaccine, yet he is exempt from ethics laws that prevent self-dealing," said Craig Holman, government affairs lobbyist for Public Citizen. "It is deeply troubling that Trump has appointed a pharmaceutical executive and private contractor to help award these massive and critical government contracts."

In most similar situations, explained Public Citizen in a statement, "people who are appointed to lead government programs or instruct other government employees, and who are supervised by senior government officials, are classified as government employees subject to conflict of interest laws and disclosure requirements. This is to ensure that employees or agents working on the government's behalf serve the public interest."

"Slaoui's blatant ties to Big Pharma, including the very drug corporations he's funneling money to, should make even the Trump administration blush," said Margarida Jorge, campaign director of Lower Drug Prices Now.

"The Trump administration continues to put corporate cronyism and profits for pharmaceutical executives ahead of public health," Jorge added. "To guarantee affordable medicines for COVID-19, Congress must block monopoly control over prices and pass safeguards that prevent corporations and shareholders from profiteering off the pandemic."


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

Trump Turns to SCOTUS Over Mar-a-Lago Docs, But 'It Won't Stop DOJ'

"This is a very specific and narrow request by Trump the merits of which turn on a technical jurisdictional question, but which runs into fatal procedural obstacles long before that," said one analyst. "It's not laughable, but only because it's small."

Jessica Corbett ·


Despite Calls for Diplomacy to End War, US Confirms More Weapons Headed to Ukraine

"Are there still negotiation possibilities?" asked Noam Chomsky. "There's only one way to find out. That's to try. If you refuse to try, of course, there's no option, no possibilities."

Brett Wilkins ·


Groups Warn SCOTUS May Gut 'Foundational' Digital Rights Law

"Weakening Section 230 would be catastrophic—disproportionately silencing and endangering marginalized communities," said one campaigner.

Jessica Corbett ·


Report Reveals How Utilities' Climate Pledges Amount to 'Textbook Greenwashing'

Despite the passage of nearly $370 billion in renewable energy funding, the nation's utilities are squandering "a massive opportunity for clean electricity and electrification."

Julia Conley ·


$158,000 Cost for ALS Treatment Called 'A Poster Child' for Unjust Drug Pricing

"The price of the newly approved drug combination Relyvrio to treat ALS," said one critic, "is yet another clear and powerful example of unjustified high prices set by drug companies that ultimately exploit patients."

Jake Johnson ·

Common Dreams Logo